Promoting confidence in cost-effectiveness analyses
- PMID: 35732298
- DOI: 10.1136/bmj.o1452
Promoting confidence in cost-effectiveness analyses
Conflict of interest statement
Competing interests: We have read and understood the BMJ Group policy on declaration of interests and declare no competing interests. ASK provides guidance to Colorado and the Massachusetts Health Policy Commission on prescription drug price review processes under contracts to Brigham and Women’s Hospital but does not receive personal funding for this work. ASK’s work supported by Arnold Ventures. AJNR is a member of the Canadian Agency for Drugs and Technologies in Health pan-Canadian Oncology Drug Review Expert Review Committee. Provenance and peer review: Commissioned, not externally peer reviewed
Comment on
-
Industry sponsorship bias in cost effectiveness analysis: registry based analysis.BMJ. 2022 Jun 22;377:e069573. doi: 10.1136/bmj-2021-069573. BMJ. 2022. PMID: 35732297 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources